ES2081476T3 - Uso de acidos grasos especificos en la fabricacion de un medicamento para su suministro por iontoforesis. - Google Patents

Uso de acidos grasos especificos en la fabricacion de un medicamento para su suministro por iontoforesis.

Info

Publication number
ES2081476T3
ES2081476T3 ES91908337T ES91908337T ES2081476T3 ES 2081476 T3 ES2081476 T3 ES 2081476T3 ES 91908337 T ES91908337 T ES 91908337T ES 91908337 T ES91908337 T ES 91908337T ES 2081476 T3 ES2081476 T3 ES 2081476T3
Authority
ES
Spain
Prior art keywords
fatty acids
iontophoresis
manufacture
supply
medicinal product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91908337T
Other languages
English (en)
Inventor
Rama V Padmanabhan
Joan M Sunram
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of ES2081476T3 publication Critical patent/ES2081476T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Electrotherapy Devices (AREA)

Abstract

SE PRESENTA UN METODO PARA LA LIBERACION TRANSDERMICA MEJORADA DE MEDICAMENTOS IONICOS MEDIANTE ELECTROTRANSPORTE, EN EL QUE SE APLICAN CIERTOS ACIDOS GRASOS SOBRE LA SUPERFICIE DEL CUERPO QUE MEJORAN LA PENETRACION DE LOS MEDICAMENTOS A TRAVES DE LA MISMA.
ES91908337T 1990-04-18 1991-04-15 Uso de acidos grasos especificos en la fabricacion de un medicamento para su suministro por iontoforesis. Expired - Lifetime ES2081476T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51050290A 1990-04-18 1990-04-18

Publications (1)

Publication Number Publication Date
ES2081476T3 true ES2081476T3 (es) 1996-03-16

Family

ID=24031010

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91908337T Expired - Lifetime ES2081476T3 (es) 1990-04-18 1991-04-15 Uso de acidos grasos especificos en la fabricacion de un medicamento para su suministro por iontoforesis.

Country Status (16)

Country Link
EP (1) EP0525063B1 (es)
JP (1) JP3261501B2 (es)
AT (1) ATE131733T1 (es)
AU (1) AU650879B2 (es)
CA (1) CA2078998A1 (es)
DE (1) DE69115687T2 (es)
DK (1) DK0525063T3 (es)
ES (1) ES2081476T3 (es)
FI (1) FI924724A7 (es)
GR (1) GR3018883T3 (es)
IE (1) IE73245B1 (es)
NO (1) NO924029L (es)
NZ (1) NZ237489A (es)
PT (1) PT97410B (es)
WO (1) WO1991016077A1 (es)
ZA (1) ZA912192B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996002232A1 (en) * 1994-07-13 1996-02-01 Alza Corporation Composition and method for enhancing transdermal electrotransport agent delivery
US5990179A (en) * 1995-04-28 1999-11-23 Alza Corporation Composition and method of enhancing electrotransport agent delivery
US5985316A (en) * 1995-04-28 1999-11-16 Alza Corporation Composition and method of enhancing electrotransport agent delivery
US6757560B1 (en) 1999-04-09 2004-06-29 Novosis Pharma Ag Transdermal delivery system (TDS) with electrode network
DE19816143A1 (de) 1998-04-09 1999-10-21 Fischer Wilfried Transdermales Applikationssystem (TDS) mit Elektrodenraster
DE50307646D1 (de) 2003-03-12 2007-08-23 Novosis Ag Transdermales Wirkstoffverabreichungssystem mit Elektrodenraster
DE102007020799A1 (de) 2007-05-03 2008-11-06 Novosis Ag Transdermales therapeutisches System mit Remifentanil
DE102007021549A1 (de) 2007-05-08 2008-11-13 Novosis Ag Transdermales therapeutisches System enthaltend mindestens zwei Opioide
DE102007058504A1 (de) 2007-12-05 2009-07-09 Acino Ag Transdermales therapeutisches System mit einem Gehalt an einem Modulator für nikotinische Acetylcholinrezeptoren (nAChR)
DE102010024558B4 (de) 2010-06-22 2016-04-21 Amw Gmbh Transdermales therapeutisches System mit Elektroden
CN115436538B (zh) * 2022-09-17 2023-08-01 山东省计量科学研究院 一种肉类食品基体兽药残留标准物质制备装置与方法
DE102024003705A1 (de) 2024-11-12 2026-05-13 Alienworks S.A. Transdermales Pflaster zur gesteuerten Abgabe von Wirkstoffen unter Verwendung einer elektronischen Regelautomatik in Form einer Smartwatch

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4626539A (en) * 1984-08-10 1986-12-02 E. I. Dupont De Nemours And Company Trandermal delivery of opioids
WO1988009676A1 (en) * 1987-06-01 1988-12-15 Warner-Lambert Company Fatty acids and their small chain esters as penetration enhancers in aqueous systems
EP0351897A3 (en) * 1988-06-17 1990-03-21 The Procter & Gamble Company Skin penetration system for salts of amine-functional drugs

Also Published As

Publication number Publication date
DE69115687T2 (de) 1996-07-18
PT97410A (pt) 1992-01-31
IE911280A1 (en) 1991-10-23
JP3261501B2 (ja) 2002-03-04
NO924029D0 (no) 1992-10-16
EP0525063A1 (en) 1993-02-03
NO924029L (no) 1992-10-16
WO1991016077A1 (en) 1991-10-31
ATE131733T1 (de) 1996-01-15
DE69115687D1 (de) 1996-02-01
AU7750091A (en) 1991-11-11
AU650879B2 (en) 1994-07-07
FI924724A0 (fi) 1992-10-19
CA2078998A1 (en) 1991-10-19
FI924724L (fi) 1992-10-19
DK0525063T3 (da) 1996-01-29
EP0525063B1 (en) 1995-12-20
PT97410B (pt) 1998-08-31
FI924724A7 (fi) 1992-10-19
ZA912192B (en) 1992-01-29
JPH05506232A (ja) 1993-09-16
GR3018883T3 (en) 1996-05-31
IE73245B1 (en) 1997-05-21
NZ237489A (en) 1995-07-26

Similar Documents

Publication Publication Date Title
ES2054860T5 (es) Derivados de 9-halogeno-(z)-prostaglandinas, procedimiento para su preparacion y su utilizacion como medicamentos.
ES2032016T3 (es) Un procedimiento para la produccion de las 13, 14-ceto-pgfs.
MX163284A (es) Bases de liberacion controlada para productos farmaceuticos
DK393187A (da) Laegemiddel med antitumorvirkning
ES2037385T3 (es) Un procedimiento de manufactura de una preparacion farmaceutica para administracion local.
ES2038718T3 (es) Sistema terapeutico transdermal para la aplicacion de productos activos sobre la piel.
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
ES2057124T3 (es) Producto terapeutico para el tratamiento de estados peri- o post-menopausicos.
ES2033682T3 (es) Procedimiento para preparar una composicion farmaceutica que contiene acido 2-(2-fluoro-4-bifenilil)propionico o una de sus sales.
ES8500276A1 (es) Procedimiento para preparar n2-acil-9-(1,3-dihidroxi-2-propoximetil)-guaninas y sus sales famaceuticamente aceptables.
AR242711A1 (es) Pelicula laminada bicomponente, el proceso para obtenerla y el articulo absorbente desechable que la incluye.
ES2182161T3 (es) Utilizacion de derivados de pirimidina para la preparacion de un medicamento para la prevencion del cancer.
ES2040106T3 (es) Utilizacion de la acetil d-carnitina en el tratamiento terapeutico del glaucoma.
ES2176197T3 (es) Sistema de administracion transdermal que contiene un acido acetilsalicilico para la terapia de trombosis y la profilaxis del cancer.
ES2053778T3 (es) Procedimiento para la obtencion de derivados del tiazol.
ES2055035T3 (es) Un proceso para la preparacion de un glicosido de antraciclina.
ES2038593T3 (es) Un procedimiento para preparar manosil-aglicona del antibiotico a 40926.
AR229713A1 (es) Aplicador para el suministro a presion de productos fluibles tales como vacunas que se aplican por inyeccion
DK0457849T3 (da) Klæbemiddel til elektrotransport
ES2013796A6 (es) Agente cosmetico a base de derivados de pirimidina y retinoides, y procedimiento para prepararlo.
ES2139965T3 (es) Benzoilguanidinas sustituidas con grupos de caracter basico, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento que las contiene.
MX9301746A (es) Nuevos acidos 9-fluor-7-oxo-7h-pirido(1,2,3,-de)(1,4)-benzoxacin-6-carboxilicos y sus esteres, procedimiento para su preparacion y medicamentos que los contienen.
MX9301608A (es) Acidos 7-oxo-7h-pirido(1,2,3,de)(1,4)benzoxacin-6-carboxilico y sus esteres, procedimiento para su preparacion y medicamentos que los contienen.
ES2038064B1 (es) Instalacion portatil de vacunacion aviar.
PT97410A (pt) Processo de preparacao de composicoes farmaceuticas para a distribuicao de drogas por electrotransporte, de producao de reservatorio e de conjunto de distribuicao de drogas por electrotransporte

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 525063

Country of ref document: ES